| Date | Time | Source | Headline | Symbol | Company |
| 07/03/2013 | 08:57 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 15/02/2013 | 07:57 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 08/02/2013 | 08:29 | Edgar (US Regulatory) | Proxy Statement - Merger or Acquistion (definitive) (defm14a) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 06/02/2013 | 09:12 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 06/02/2013 | 09:10 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 06/02/2013 | 09:10 | Edgar (US Regulatory) | Definitive Materials Filed by Investment Companies. (497) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 06/02/2013 | 08:30 | GlobeNewswire Inc. | Somaxon Pharmaceuticals Announces Settlement of Silenor Patent Litigation With Actavis | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 05/02/2013 | 08:41 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 05/02/2013 | 08:32 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 02/02/2013 | 09:06 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 02/02/2013 | 09:04 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 29/01/2013 | 04:21 | Zacks | PTX Reduces Sales Force, CFO Quits - Analyst Blog | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 19/01/2013 | 08:23 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 05/01/2013 | 05:15 | Zacks | Pernix Acquires Cypress and Hawthorn - Analyst Blog | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 04/01/2013 | 11:02 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 04/01/2013 | 11:01 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 04/01/2013 | 10:55 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 04/01/2013 | 10:55 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 04/01/2013 | 10:54 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 04/01/2013 | 10:54 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 04/01/2013 | 10:52 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 04/01/2013 | 10:52 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 04/01/2013 | 10:51 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 04/01/2013 | 10:51 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 04/01/2013 | 10:47 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 04/01/2013 | 10:47 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 04/01/2013 | 10:46 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 04/01/2013 | 10:46 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 04/01/2013 | 10:46 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 04/01/2013 | 10:46 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |